| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 01/24/2006 | US6989383 Method of treating cancer |
| 01/24/2006 | CA2350881C Wet adhesion monomer and derived copolymers for latex paints |
| 01/24/2006 | CA2143419C Novel method for preparing ergothioneine |
| 01/19/2006 | US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus |
| 01/19/2006 | US20060014805 Pesticidal fluoroalkene derivatives |
| 01/19/2006 | US20060014792 Heterocyclo inhibitors of potassium channel function |
| 01/19/2006 | US20060014783 Sulfonylamino-acetic acid derivatives |
| 01/19/2006 | US20060014781 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging |
| 01/19/2006 | US20060014743 Methods of preventing bacterial infections with florfenicol-type antibiotics |
| 01/19/2006 | CA2571572A1 Mitotic kinesin inhibitors |
| 01/18/2006 | EP1616865A1 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas |
| 01/18/2006 | EP1615904A2 Substituted benzosulphonamide as potentiators of glutamate receptors |
| 01/18/2006 | EP1615892A2 Benzamide 2-hydroxy-3-diaminoalkanes |
| 01/18/2006 | EP1615866A1 Indene derivatives as pharmaceutical agents |
| 01/18/2006 | EP1435951B1 Phenyl substituted 5-membered nitrogen containing heterocycles for the tretment of obesity |
| 01/18/2006 | CN1723207A Inhibitors of histone deacetylase |
| 01/18/2006 | CN1723202A Process for preparing substituted imidazole derivates and intermediates used in the process |
| 01/18/2006 | CN1721410A Process for microwave synthesis of 1,3-disubstituted imidazole-2-thioketone |
| 01/18/2006 | CN1721401A Inhibitors of LFA-1 binding to ICAMS and uses thereof |
| 01/17/2006 | US6987193 Illudin analogs useful as antitumor agents |
| 01/17/2006 | US6987120 Pharmaceutical compounds |
| 01/17/2006 | US6986795 One cationic group Z, Z being chosen from quaternized aliphatic chains, aliphatic chains containing at least one quaternized saturated ring and aliphatic chains containing at least one quaternized unsaturated ring, their use as direct |
| 01/12/2006 | WO2006002875A1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
| 01/12/2006 | WO2006002874A1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain 1, 4, 7, 10-tertraazacyclodecan-1, 4, 7-triacetic acid chelating moiety with polyhydroxylated substituents |
| 01/12/2006 | WO2006002873A2 1 , 4 -bis (carboxymethyl) -6- ' bis ( carboxymethyl) amino ! -6 -methyl- perhydro-1 , 4 diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri ) |
| 01/12/2006 | WO2005105079A3 Novel imidazoles |
| 01/12/2006 | WO2005092066A3 Imidazole compounds |
| 01/12/2006 | US20060009645 Naphthylene derivatives as cytochrome P450 inhibitors |
| 01/12/2006 | US20060009528 Cannabinoid receptor ligands |
| 01/12/2006 | US20060009511 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor |
| 01/12/2006 | US20060009472 Substituted imidazole derivatives |
| 01/12/2006 | US20060009446 New compounds |
| 01/12/2006 | US20060008670 Organic light emitting materials and devices |
| 01/12/2006 | CA2572316A1 Imidazolo-related compounds, compositions and methods for their use |
| 01/12/2006 | CA2569727A1 Compounds |
| 01/12/2006 | CA2565683A1 Substituted azepine derivatives as serotonin receptor modulators |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1613615A2 4-ring imidazole derivatives as modulators of metabotropic glutamate receptor-5 |
| 01/11/2006 | EP1613612A2 Bioreductively-activated prodrugs |
| 01/11/2006 | EP1613604A1 1-imidazolylmethyl-substituted-2-naphtols and their use as accelerators for low-temperature curing |
| 01/11/2006 | EP1613368A2 Carboxamide spirohydantoin cgrp receptor antagonists |
| 01/11/2006 | EP1613311A2 Hif-1 inhibitors |
| 01/11/2006 | EP1613310A1 Imidazole derivatives for treatment of allergic and hyperproliferative disorders |
| 01/11/2006 | EP1491206A4 Induction method for cell differentiation |
| 01/11/2006 | EP1366036B1 Compounds having activity as inhibitors of cytochrome p450rai |
| 01/11/2006 | EP1131315B1 Polyhydroxylated heterocyclic derivatives as anti-coagulants |
| 01/11/2006 | CN1720235A 1-N-phenylamino-1h-imidazole derivatives as aromatase inhibitors |
| 01/11/2006 | CN1720043A Non-nucleoside reverse transcriptase inhibitors |
| 01/11/2006 | CN1235883C Chiral ion liquid of alkylimidazole tetrafluoroborate and its preparation |
| 01/11/2006 | CN1235879C Process for preparing room temperature ionic liquid |
| 01/11/2006 | CN1235870C Novel use of phenyl hetero alkylamine derivatives |
| 01/10/2006 | USRE38934 Method and reagents for N-alkylating ureides |
| 01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
| 01/10/2006 | US6984645 Aryl carboxylic acids and tetrazoles for treating diabetes, especially type II diabetes |
| 01/10/2006 | US6984634 For prophylaxis and therapy |
| 01/10/2006 | CA2135541C Process for the preparation of 2-substituted 5-chloroimidazole-4-carbaldehydes |
| 01/10/2006 | CA2129897C Coa-it and paf inhibitors |
| 01/05/2006 | WO2006002236A1 N- (1- (1-benzyl -4-phenyl-1h-imidazol-2-yl) -2,2-dymethylpropyl) benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer |
| 01/05/2006 | WO2006001750A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders |
| 01/05/2006 | US20060004103 Method for producing lysine derivative |
| 01/05/2006 | US20060004075 Substituted aryl amides as IP antagonists |
| 01/05/2006 | US20060004074 e.g. 1-(but-2-ynyl)-2-(3-amino-piperidin-1-yl)-5-(naphth-1-ylmethylaminocarbonyl)-1H-imidazole; dipeptidylpeptidase-IV inhibitor; antidiabetic, anticarcinogenic, antiinflammatory agent; autoimmune, neurodegenerative diseases; |
| 01/05/2006 | US20060004063 Inhibitors of HCV NS5B polymerase |
| 01/05/2006 | US20060004062 Compounds for inhibiting insulin secretion and methods related thereto |
| 01/05/2006 | US20060004059 Substituted heterocycles for the treatment of diabetes and other diseases |
| 01/05/2006 | US20060004013 Cinnamide compound |
| 01/05/2006 | US20060002991 Ph-sensitive cationic lipids, and liposomes and nanocapsules containing the same |
| 01/05/2006 | CA2571002A1 N-(1-(1-benzyl-4-phenyl-1h-imidazol-2-yl)-2,2-dimethylpropyl)benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer |
| 01/05/2006 | CA2570619A1 Imidazole variants as modulators of gaba receptor for the treatment of gi disorders |
| 01/04/2006 | EP1612204A1 Hydrazone derivative |
| 01/04/2006 | EP1611902A1 Preventive and/or therapeutic agent for neuropathic pain |
| 01/04/2006 | EP1611120A1 Novel methods for the treatment of inflammatory diseases |
| 01/04/2006 | EP1611091A1 Novel compounds |
| 01/04/2006 | EP1610812A1 Pharmaceutical preparations comprising acid-stabilised insulin |
| 01/04/2006 | EP1610790A2 Anticancer compounds |
| 01/04/2006 | EP1610780A2 Cyclic protein tyrosine kinase inhibitors |
| 01/04/2006 | EP1363873A4 Peptide deformylase inhibitors |
| 01/04/2006 | EP1169298B1 Pharmaceutical compounds |
| 01/04/2006 | CN1234694C New imidazoline compound, its preparation method and drug composition containing them |
| 01/04/2006 | CN1234367C Arylazo-substituted imidazole for treatment of stress urinary incontinence |
| 01/03/2006 | US6982335 Synthesis of substituted thiazoline carboxylic acids |
| 01/03/2006 | US6982264 Enzyme inhibitors of beta-secretase-mediated cleavage of amyloid precuror proteins; congnition activators; Down's syndrome; Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-type; Parkinson's disease; hemostatic agents |
| 01/03/2006 | US6982259 N-heterocyclic derivatives as NOS inhibitors |
| 12/29/2005 | WO2005123703A2 Alkynyl derivatives as modulators of metabotropic glutamate receptors |
| 12/29/2005 | WO2005123691A1 Novel cis-imidazolines |
| 12/29/2005 | WO2005123050A2 Five-membered heterocycles useful as serine protease inhibitors |
| 12/29/2005 | US20050288508 Catalytic depolymerization of polymers containing electrophilic linkages using nucleophilic reagents |
| 12/29/2005 | US20050288320 Induce biosymthesis of cytokines, interferons, tumor necrosis factor; antitumor agents; viricides; chemical intermediates |
| 12/29/2005 | US20050288303 Cyclic protein tyrosine kinase inhibitors |
| 12/29/2005 | US20050288287 Chiral cis-imidazolines |
| 12/29/2005 | US20050288282 Anticancer agents; antiproliferative agents |
| 12/29/2005 | US20050288275 New compounds |
| 12/29/2005 | US20050288238 Benzocyclodecane derivatives with antitumor activity |
| 12/29/2005 | US20050288228 Bile-acid conjugates for providing sustained systemic concentrations of drugs |
| 12/29/2005 | CA2570472A1 Five-membered heterocycles useful as serine protease inhibitors |
| 12/29/2005 | CA2569598A1 Novel cis-imidazolines |
| 12/28/2005 | EP1609362A2 Non-systemic control of parasites |
| 12/28/2005 | EP1608627A2 Bicyclic anilide spirohydantoin cgrp receptor antagonists |
| 12/28/2005 | EP1608339A1 Pharmaceutical co-crystal compositions of drugs such as carbamazepine, celecoxib, olanzapine, itraconazole, topiramate, modafinil, 5-fluorouracil, hydrochlorothiazide, acetaminophen, aspirin, flurbiprofen, phenytoin and ibuprofen |